Categories: News

Ibogaine By David Dardashti Begins Inflammation Tests to Demonstrate Adequate Results

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Doctor Ashok Bharucha Proposes That Ibogaine Can Help Improve Immune System Functionality

Doctor Ashok Bharucha

Harvard doctor helping those with ibogaine treatment.Harvard doctor helping those with ibogaine treatment.
Harvard doctor helping those with ibogaine treatment.

MIAMI, April 26, 2024 (GLOBE NEWSWIRE) — Ibogaine By David Dardashti is taking proactive steps to prove the efficacy of ibogaine hydrochloride in improving inflammation levels in the body.

Managing Inflammation With increasing evidence that people with healthy inflammation levels are more likely to survive severe illnesses, ibogaine hydrochloride has become an increasingly popular option for those looking to protect their long term wellbeing. To demonstrate these effects, Ibogaine By David Dardashti has launched a comprehensive in-clinic testing program to gauge the effects of ibogaine on the body’s inflammatory levels. As Doctor Ashok Bharucha from the clinic explains, “Ibogaine has long been understood to be a powerful factor in healthy inflammation and balancing the body’s essential fluids. We are now able to test these effects in a laboratory and begin to provide tailored advice to help individuals find a pathway to long-term health.” The clinic also suggests that the ibogaine treatment is only one part of a larger lifestyle-based approach to managing inflammation and optimizing the immune system. Doctor Bharucha states, “The key to achieving and maintaining a healthy inflammation level is a lifestyle based approach. Taking ibogaine hydrochloride is a great way to start the process, but of course diet, exercise, exposure to healthy environmental conditions, herbal remedies, and other lifestyle factors are all essential.”

Ibogaine By David Dardashti has launched a comprehensive in-clinic testing program to gauge the effects of ibogaine on the body’s inflammatory levels, and emphasizes the need for a comprehensive lifestyle-based approach to managing inflammation and optimizing the immune system.

Ibogaine By David Dardashti is therefore encouraging anyone who is interested in exploring the ibogaine treatment to get in contact and arrange a preliminary consultation.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/1bac555f-8390-4061-9731-fd917cfb30ab

CONTACT: David Dardashti
+17869301880
gavriel@ibogaineclinic.com

Staff

Recent Posts

MedsEngine Achieves SOC 2 Type II Certification: Reinforcing Our Commitment to Data Security

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine, a provider of chronic disease management software, is proud to announce that…

53 minutes ago

cbdMD, Inc. Announces Automatic Conversion Date of Series A Preferred Stock and One for Eight Reverse Split of its Common Stock Immediately Following the Automatic Conversion

Charlotte, North Carolina--(Newsfile Corp. - April 21, 2025) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

10 hours ago

Onsite Mammography Provides Notice of Data Incident

BOSTON, April 21, 2025 /PRNewswire/ -- Onsite Mammography ("Onsite") announces a data incident that impacted…

13 hours ago

Lumenis Unveils Enhanced SPLENDOR X™ Laser Hair Removal Solution with New Clinical Data at the Annual American Society for Laser Medicine and Surgery (ASLMS) Conference

New data demonstrates effectiveness of SPLENDOR X™'s dual-wavelength simultaneous laser emission technology for improved hair…

13 hours ago

Havas Health Network and Republica Havas Health Unveil Report on Inequities in HCP Training and Practices

"The Hidden Divide" Exposes Gaps in Healthcare Provider Education and Care Delivery MIAMI, April 21,…

19 hours ago

K-679: A Novel Antibody Drug-loaded Unimicelle Conjugate with Ultra-High Drug Loading Capacity Demonstrates Superior Efficacy in EGFR-Expressing Solid Tumors

NAGOYA, Japan, April 21, 2025 /PRNewswire/ -- Kowa Company, Ltd. (Headquarters: Nagoya, Aichi Prefecture, Japan), today announced…

19 hours ago